Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedNew revision label v3.6.4 was added to the study record history, replacing the previous v3.6.3. This indicates a minor update to the page history rather than a change to the study data or content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.6.3 was added to the study record history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe study record title was updated to use the uHCC abbreviation and corrected wording, and the recruitment status was changed to Active, not recruiting; additional sections such as Contacts/Locations, Eligibility, Outcome Measures, and Arms and Interventions were added.SummaryDifference2%

- Check45 days agoChange DetectedThe Record History page now includes links to 'Check who can join' and 'Find Contact Information' and shows the revision label updated to v3.6.0 from v3.5.5.SummaryDifference0.5%

- Check52 days agoChange DetectedThe page now shows the latest site revision as v3.5.5, replacing v3.5.4. This indicates a platform update that does not change the trial data.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page's revision label in the Record History updated from v3.5.3 to v3.5.4, indicating a small update to the site’s versioning metadata. The change does not modify the study data or primary content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.